v3.26.1
CONDENSED BALANCE SHEETS (Unaudited) - USD ($)
Jun. 30, 2026
Dec. 31, 2025
Current assets    
Cash equivalents $ 229,394 $ 6,081
Due from Sponsor 192,493
Prepaid expense 34,554
Prepaid insurance 85,400
Total Current Assets 541,841 6,081
Deferred offering costs 587,984
Cash and marketable securities held in Trust Account 174,896,125
TOTAL ASSETS 175,437,966 594,065
Current liabilities    
Accrued expenses 890,106 60,417
Accrued offering costs 208,270 401,313
Promissory note – related party 217,513
Total Current Liabilities 1,098,376 679,243
Deferred underwriting fee payable 12,075,000
Total Liabilities 13,173,376 679,243
Class A Ordinary Shares subject to possible redemption, 17,250,000 and 0 shares at redemption value of $10.14 and $0 per share as of June 30, 2026 and December 31, 2025, respectively 174,896,125
Shareholders’ Deficit    
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued or outstanding as of June 30, 2026 and December 31, 2025
Additional paid-in capital 24,425
Accumulated deficit (12,632,215) (110,178)
Total Shareholders’ Deficit (12,631,535) (85,178)
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit 175,437,966 594,065
Class A Ordinary Shares [Member]    
Shareholders’ Deficit    
Common stock value 105
Class B Ordinary Shares [Member]    
Shareholders’ Deficit    
Common stock value [1] $ 575 $ 575
[1] This number includes an aggregate of up to 750,000 Class B Ordinary Shares that were subject to forfeiture if the over-allotment option had not been exercised in full or in part by the underwriters. On February 9, 2026, the underwriters exercised their over-allotment option in full to be settled as part of the closing of the Initial Public Offering (as defined in Note 1). As a result of the underwriters’ election to fully exercise their over-allotment option, those 750,000 Founder Shares are no longer subject to forfeiture by the Sponsor (see Note 4).